PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9380605

[Thyroid nodule. Differential diagnostic guidelines].

K W Schmid
View original source ↗Export metadata ↓

Abstract

Nodules in the thyroid are common. They may represent hyperplastic or adenomatous nodules, true adenomas or malignant neoplasms. The main task of the pathologist consists of the exclusion or demonstration of malignancy. This can be done preoperatively by fine needle aspiration (FNA) cytology, intraoperatively by frozen section diagnosis, and postoperatively by investigation of paraffin sections. The intention of this paper is to formulate guidelines for the diagnosis and differential diagnosis of thyroid nodules. The evaluation of thyroid nodules still depends on routine cytological or histological specimens since immunohistochemistry, flow-cytometry and molecular biological techniques sofar failed to provide significant aid in the process of distinguishing benign from malignant thyroid nodules.

Explore related subjects

AdenomaBiopsy, NeedleCarcinomaCell Transformation, NeoplasticDiagnosis, DifferentialHumansHyperplasiaPractice Guidelines as TopicThyroid GlandThyroid NeoplasmsThyroid NoduleEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K W Schmid. 1997. [Thyroid nodule. Differential diagnostic guidelines].. https://doi.org/10.1007/s002920050219

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2009

HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas.

The high mobility group As (HMGAs) belong to a family of nonhistone nuclear proteins that orchestrate the assembly of nucleoprotein complexes. Through a complex network of protein-DNA and protein-protein interaction, they play important roles in gene transcription, recombination, and chromatin structure. This protein family is involved, through different mechanisms, in both benign and malignant neoplasias. We have recently reported that transgenic mice carrying the Hmga1 or Hmga2 genes under transcriptional control of the cytomegalovirus promoter develop pituitary adenomas secreting prolactin and growth hormone. We have shown that the mechanism of the HMGA2-induced pituitary adenoma is based on the increased E2F1 activity. The expression profile of mouse normal pituitary glands and adenomas induced in HMGA transgenic mice revealed an increased expression of the ccnb2 gene, coding for the cyclin B2 protein, in the neoplastic tissues compared with the normal pituitary gland. Here, we show, by electrophoretic mobility shift assay and chromatin immunoprecipitation, a direct binding of HMGA proteins to the promoter of ccnb2 gene, whereas luciferase assays showed that HMGAs are able to up-regulate ccnb2 promoter activity. Finally, we report an increased CCNB2 expression in human pituitary adenomas of different histotypes that is directly correlated with HMGA1 and HMGA2 expression. Because cyclin B2 is involved in the regulation of the cell cycle, these results taken together indicate that HMGA-induced cyclin B2 overexpression gives an important contribution to experimental and human pituitary tumorigenesis.

Adenoma↗
PubMed1999

Hypermethylation of the MYF-3 gene in colorectal cancers: associations with pathological features and with microsatellite instability.

Myf-3 is the human homologue of the murine Myo-D1 gene involved in muscle-cell differentiation. Using Southern blot analysis, we examined methylation of Myf-3 in histologically normal colonic mucosae, adenomas and carcinomas from a large series of patients with primary colorectal cancer. Hypermethylation of this gene in comparison with normal mucosa was observed in 88% of adenomas and in 99% of carcinomas. The pattern of Myf-3 methylation was similar in different areas of the same tumour, suggesting that methylation imbalances occur before the bulk of clonal-cell expansion. Significantly increased levels of Myf-3 methylation were observed in tumours which were more invasive, located in the proximal colon or from older patients. Patients whose tumours had extensive methylation showed a trend for shortened survival, though this was probably related to their being more invasive. Extensive methylation was significantly more frequent in tumours with microsatellite instability. Further work is required to determine whether the hypermethylation of Myf-3 observed in colorectal cancers is a specific alteration with functional significance or whether it reflects non-specific methylation imbalances occurring early during tumorigenesis.

Adenoma↗